MalarVX Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $217K

  • Investors
  • 3

MalarVX General Information

Description

Operator of a biopharmaceutical company intended to help eradicate falciparum malaria worldwide. The company is focused on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine, providing the medical industry with a safe, effective, and affordable malaria vaccine.

Contact Information

Website
www.malarvx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1551 Eastlake Avenue East
  • Suite 100
  • Seattle, WA 98102-3788
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1551 Eastlake Avenue East
  • Suite 100
  • Seattle, WA 98102-3788
  • United States
+1 (206)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MalarVX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 21-Sep-2020 $217K Completed Pre-Clinical Trials
3. Grant 01-Jan-2019 Completed Pre-Clinical Trials
2. Seed Round 21-Jun-2017 $1.05M $1.8M Completed Pre-Clinical Trials
1. Angel (individual) 23-Nov-2015 $750K $750K Completed Pre-Clinical Trials
To view MalarVX’s complete valuation and funding history, request access »

MalarVX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to help eradicate falciparum malaria worldwide. The company is focused
Drug Discovery
Seattle, WA
6 As of 2023

Barcelona, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MalarVX Competitors (1)

One of MalarVX’s competitors is Ability Pharma, a Private Equity-Backed company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Barcelona, Spain
You’re viewing 1 of 1 competitors. Get the full list »

MalarVX Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

MalarVX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4511058-A1 Compositions, devices, systems and methods relating to vaccination and sterile protection against malaria Pending 22-Apr-2023

MalarVX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MalarVX Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
United States Department of Defense Government
Keiretsu Forum Angel Group Minority
To view MalarVX’s complete investors history, request access »

Ready to get started?

Request a free trial

MalarVX FAQs

  • When was MalarVX founded?

    MalarVX was founded in 2012.

  • Where is MalarVX headquartered?

    MalarVX is headquartered in Seattle, WA.

  • What is the size of MalarVX?

    MalarVX has 6 total employees.

  • What industry is MalarVX in?

    MalarVX’s primary industry is Drug Discovery.

  • Is MalarVX a private or public company?

    MalarVX is a Private company.

  • What is MalarVX’s current revenue?

    The current revenue for MalarVX is .

  • How much funding has MalarVX raised over time?

    MalarVX has raised $1.8M.

  • Who are MalarVX’s investors?

    National Institutes of Health, United States Department of Defense, and Keiretsu Forum have invested in MalarVX.

  • Who are MalarVX’s competitors?

    Ability Pharma is a competitor of MalarVX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »